Preliminary Results of Concurrent Chemotherapy and Radiation Therapy using High-dose-rate Brachytherapy for Cervical Cancer |
Lee, Kyung-Ja
(Department of Radiation Oncology, Mokdong Hospital, Ewha Womans University)
Lee, Ji-Hye (Department of Radiation Oncology, Mokdong Hospital, Ewha Womans University) Lee, Re-Na (Department of Radiation Oncology, Mokdong Hospital, Ewha Womans University) Suh, Hyun-Suk (Department of Radiation Oncology, Mokdong Hospital, Ewha Womans University) |
1 | Morris M, Eifel PJ, Lu J, et al. Pelvic radiation with concurrent chemotherapy compared with pelvic and par-aortic radiation for high-risk cervical cancer. N Engl J Med 1999;340:1137-1143 DOI ScienceOn |
2 | Whitney CW, Sause W, Bundy BN, et al. Randomized comparison of fluorouracil plus cisplatin vs. hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: a Gynecologic Oncology Group and Southwest Oncology Group study. J Clin Oncol 1999;17:1339-1348 DOI |
3 | Wong LC, Ngan HY, Cheung AN, et al. Chemoradiation and adjuvant chemotherapy in cervical cancer. J Clin Oncol 1999; 17:2055-2060 DOI |
4 | Horiot JC, Pigneux J, Pourquier H, et al. Radiotherapy alone in carcinoma of the intact uterine cervix according to G.H Fletcher guideline: a French cooperative study of 1,983 cases. Int J Radiat Oncol Biol Phys 1988;14:605-611 DOI ScienceOn |
5 | International Commission on Radiation Units and Measurements. Dose and volume specification for reporting intracavitary therapy in gynecology. ICRU Rep. vol. 38. Washington; ICRU, 1985 |
6 | Peters WA, Liu PY, Baret RJ, et al. Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix. J Clin Oncol 2000; 18:1606-1613 DOI |
7 | Lanciano R. Optimizing radiation parameters for cervical cancer. Semin Radiat Oncol 2000;10:36-43 DOI ScienceOn |
8 | Orgino I, Kitamura T, Okamoto N, et al. Late rectal complication following high-dose-rate intracavitary brachytherapy in caner of the cervix. Int J Radiat Oncol Biol Phys 1995;31 :725-734 DOI ScienceOn |
9 | Toita T, Moronmizato H, Ogawa K, et al. Concurrent chemoradiotherapy using high-dose-rate intracavitary brachytherapy for uterine cervical cancer. Gynecol Oncol 2005;96:665-670 DOI ScienceOn |
10 | Green JA, Kilwan JM, Tierney JF, et al. Survival and recurrence after concomitant chemotherapy and radiotherapy for cancer of the uterine cervix: a systematic review and meta-analysis. Lancet 2001;258:781-786 |
11 | Lunciano R, Calkins A, Bundy BN, et al. Randomized comparison of weekly cisplatin or protracted venous infusion of fluorouracil in combination with pelvic radiation in advanced cervix cancer: a Gynecologic Oncology Group study. J Clin Oncol 2005;23:8289-8295 DOI ScienceOn |
12 | Nag S, Erickson B, Thomadsen B, et al. For the American Brachytherapy Society. The American Brachytherapy Society recommendations for high-dose-rate brachytherapy for carcinoma of the cervix. Int J Radiat Oncol Biol Phys 2000; 48:201-211 DOI ScienceOn |
13 | Folwer JF. The linear-quadratic formula and program in fractionated radiotherapy. Br J Radiol 1989;62:679-694 DOI ScienceOn |
14 | Rose PG, Bundy BN, Watkins EB, et al. Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. N Engl J Med 1999;340:1144-1153 DOI ScienceOn |
15 | Eifel PJ, Winter K, Morris M, et al. Pelvic irradiation with concurrent chemotherapy versus pelvic and para-aortic irradiation for high-risk cervical cancer. An update of radiation therapy oncology group trial (RTOG) 90-01. J Clin Oncol 2004;22: 872-880 DOI |
16 | Petereit DG, Pearcey R. Literature analysis of high dose rate brachytherapy fractionation schedules in the treatment of cervical cancer: Is there an optimal fractionation schedule? Int J Radiat Oncol Biol Phy 1999;43:359-366 DOI ScienceOn |
17 | Lukka H, Hirte H, Fyles A, et al. Concurrent cisplatinbased chemotherapy plus radiotherapy for cervcial cancer - a meta-analysis. Clin Oncol 2002;14:203-212 DOI ScienceOn |
18 | Strauss HG, Kuhnt T, Laban C, et al. Chemoradiation in cervical cancer with cisplatin and high-dose-rate brachytherapy combined with external beam radiotherapy: results of a phase-II study. Strahlenther Onkol 2002;178:378-385 DOI |
19 | NCI Clinical Announcement: Concurrent chemoradiation for cervical cancer. Washington, DC; United States Department of Public Health, February 1999 |
20 | Clark BG, Souhami L, roman TN, et al. Rectal complications in patients with irradiation with high-dose-rate brachytherapy: a dosimetric analysis. Int J Raddat Oncol Biol Phys 1994;28:1243-1250 DOI ScienceOn |
21 | Clark BG, Souhami L, Roman TN, et al. The prediction of late rectal complications in patients treated with high-doserate brachytherapy for carcinoma of the cervix. Int J Radiat Oncol Biol Phys 1997;38:989-993 DOI ScienceOn |
22 | Toita T, Kakinohna Y, Ogawa K, et al. Combination external beam radiotherapy and high-dose-rate intracavitary brachytherapy for uterine cervical cancer: analysis of dose and fractionation schedule. Int J Radiat Oncol Biol Phys 2003;56: 1344-1353 DOI ScienceOn |
23 | Souhami L, Seymour R, Roman R, et al. Weekly cisplatin plus external beam radiotherapy and high dose rate brachytherapy in patients with locally advanced carcinoma of the cervix. Int J Radiat Oncol Biol Phys 1993;27:871-878 DOI ScienceOn |
24 | Stitt JA, Fowler JF, Thomadsen BR, et al. High-doserate intracavitary brachytherapy for carcinoma of the cervix: the Madison System: I. Clinical and radiobiological considerations. Int J Radiat Oncol Biol Phys 1992;24:335-348 DOI ScienceOn |
25 | Fletcher GH. Textbook of radiotherapy. 3rd ed. Philadelphia, PA; Lea & Febier, 1980:720-773 |
26 | Perez CA, Camerl HM, Kuske RR, et al. Radiation therapy alone in the treatment of carcinoma of the uterine cervix: a 20-yr experience. Gynecol Oncol 1986;23:127-140 DOI ScienceOn |
27 | Bastin KT, buchler DA, Stitt JA, et al. Resource utilization: high dose rate versus low dose rate brachytherapy for gynecologic cancer. Am J Clin Oncol 1993;16:256-263 DOI ScienceOn |
28 | Wright J, Jones G, Whelan T, et al. Patient preference for high-or low-dose-rate brachytherapy in carcinoma of the cervix. Radiother Oncol 1994;33:187-194 DOI ScienceOn |
29 | Tod M, Meredith W. A dosage system for use in the treatment of cancer of the uterine cervix. Br J RadioI 1938;11:809-824 DOI |